Tissue Factor-Independent Effects of Recombinant Factor VIIa on Hemostasis

Seminars in Hematology

Volumn 45, Issue SUPPL. 1, 2008, Pages

  Weeterings, Cees ^a   Lisman, Ton ^a,b   de Groot, Philip G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR; INTEGRIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING; DRUG EFFECT; DRUG RECEPTOR BINDING; GLANZMANN DISEASE; HEMOPHILIA; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

BLOOD COAGULATION; BLOOD PLATELET DISORDERS; FACTOR VIIA; HEMOPHILIA A; HEMOSTASIS; HUMANS; PLATELET ACTIVATION; RECOMBINANT PROTEINS; THROMBOPLASTIN;

EID: 44649172136     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2008.03.018     Document Type: Article

References (29)

1. Key N.S., and Negrier C. Coagulation factor concentrates: Past, present, and future. Lancet 370 (2007) 439-448
2. Hoyer L.W. Factor VIII inhibitors. Curr Opin Hematol 2 (1995) 365-371
3. Köhler M. Thrombogenicity of prothrombin complex concentrates. Thromb Res 95 suppl 1 (1999) S13-S17
4. Hedner U., and Kisiel W. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest 71 (1983) 1836-1841
5. Shapiro A.D., Gilchrist G.S., Hoots W.K., Cooper H.A., and Gastineau D.A. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 80 (1998) 773-778
6. Poon M.C. The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders. Transfus Med Rev 21 (2007) 223-236
7. Hedner U. Mechanism of action of factor VIIa in the treatment of coagulopathies. Semin Thromb Hemost 32 suppl 1 (2006) 77-85
8. Mannucci P.M., and Levi M. Prevention and treatment of major blood loss. N Engl J Med 356 (2007) 2301-2311
9. Lisman T., and De Groot P.G. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 1 (2003) 1138-1139
10. ten Cate H., Bauer K.A., Levi M., Edgington T.S., Sublett R.D., Barzegar S., et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 92 (1993) 1207-1212
11. Hedner U. Dosing and monitoring NovoSeven treatment. Haemostasis 26 suppl 1 (1996) 102-108
12. Björquist P., and Boström S. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance. Thromb Res 85 (1997) 225-236
13. Hoffman M., Monroe D.M., and Roberts H.R. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: Implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia. Blood 83 (1994) 38-42
14. Monroe D.M., Hoffman M., Oliver J.A., and Roberts H.R. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99 (1997) 542-547
15. Lisman T., Adelmeijer J., Cauwenberghs S., Van Pampus E.C., Heemskerk J.W., and De Groot P.G. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. J Thromb Haemost 3 (2005) 742-751
16. Lisman T., Moschatsis S., Adelmeijer J., Nieuwenhuis H.K., and De Groot P.G. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood 101 (2003) 1864-1870
17. Ruggeri Z.M., and Mendolicchio G.L. Adhesion mechanisms in platelet function. Circ Res 100 (2007) 1673-1685
18. Poon M.C., D'Oiron R., Von Depka M., Khair K., Négrier C., Karafoulidou A., et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey. J Thromb Haemost 2 (2004) 1096-1103
19. Niewiarowski S., Levy-Toledano S., and Caen J.P. Platelet interaction with polymerizing fibrin in Glanzmann's thrombasthenia. Thromb Res 23 (1981) 457-463
20. McGregor L., Hanss M., Sayegh A., Calvette J.J., Trzeciak M.C., Ville D., et al. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa. Thromb Haemost 62 (1989) 962-967
21. Soslau G., Class R., Morgan D.A., Foster C., Lord S.T., Marchese P., et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 276 (2001) 21173-21183
22. Jarvis G.E., Atkinson B.T., Frampton J., and Watson S.P. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb. Br J Pharmacol 138 (2003) 574-583
23. Lisman T., Adelmeijer J., Heijnen H.F., and De Groot P.G. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation. Blood 103 (2004) 1720-1727
24. Monroe D.M., Hoffman M., and Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22 (2002) 1381-1389
25. 2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem J 265 (1990) 327-336
26. Clemetson K.J. A short history of platelet glycoprotein Ib complex. Thromb Haemost 98 (2007) 63-68
27. Weeterings C., Adelmeijer J., de Groot P.G., and Lisman T. Glycoprotein Ib alpha contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. J Thromb Haemost 5 suppl 2 (2007) O-S-042
28. Lisman T., Weeterings C., and de Groot P.G. Platelet aggregation: Involvement of thrombin and fibrin(ogen). Front Biosci 10 (2005) 2504-2517
29. Baglia F.A., Shrimpton C.N., López J.A., and Walsh P.N. The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane. J Biol Chem 278 (2003) 21744-21750